XML 25 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities:    
Net income $ 121,277 $ 121,438
Adjustments for items not affecting cash:    
Depreciation and amortization expenses 64,912 55,586
Share-based payments expense 23,306 13,556
Deferred income tax expense 2,228 8,250
Unrealized foreign exchange (gain) loss (98) 2,049
Gain on disposition of property, plant and equipment (1,311) (1,536)
Amortization of debt issuance costs 2,155 2,375
Amortization of right-of-use assets 9,458 9,194
Gain on contingent consideration from equity investment   (1,700)
Other, net 2,253 2,427
Net changes in operating assets and liabilities 79,938 53,912
Net cash provided by operating activities 304,118 265,551
Investing activities:    
Acquisition of Rouse, net of cash acquired 728  
Property, plant and equipment additions (6,984) (9,865)
Proceeds on disposition of property, plant and equipment 1,667 16,277
Intangible asset additions (25,601) (19,886)
Issuance of loans receivable (2,622) (2,985)
Repayment of loans receivable 436 355
Distribution from equity investment   4,212
Proceeds on contingent consideration from equity investment   1,700
Net cash used in investing activities (32,376) (10,192)
Financing activities:    
Share repurchase   (53,170)
Dividends paid to stockholders (76,144) (67,639)
Acquisition of remaining interest in NCI (5,556)  
Dividends paid to NCI (104)  
Proceeds from exercise of options and share option plans 13,915 40,194
Payment of withholding taxes on issuance of shares (9,160) (3,870)
Net increase (decrease) in short-term debt (9,271) 13,442
Repayment of long-term debt (5,328) (11,134)
Debt issue costs (3,163) (2,038)
Repayment of finance lease obligations (8,445) (6,927)
Net cash used in financing activities (103,256) (91,142)
Effect of changes in foreign currency rates on cash, cash equivalents, and restricted cash (7,027) 5,826
Increase 161,459 170,043
Beginning of period 306,895 420,256
Cash, cash equivalents, and restricted cash, end of period $ 468,354 $ 590,299